Preexisting Autoimmune Disease Increases Incidence of irAEs With PD-1 Immunotherapy for Advanced Cancer
Study findings demonstrate the rates of immune-related adverse events and flares of the underlying disorders in this patient population.
Study findings demonstrate the rates of immune-related adverse events and flares of the underlying disorders in this patient population.
The American Society of Hematology released guidelines for preventing and managing venous thromboembolism in patients with cancer.
Researchers identified the risk factors for chemotherapy-induced peripheral neuropathy in cancer patients treated with paclitaxel or oxaliplatin.